More Starpharma Holdings Limited news
Starpharma Holdings LimitedASX: SPL

Starpharma clinical trial programs accelerating

Mar 30, 2016 at 5:31 AM EDT · Issued by Starpharma Holdings Limited

Filed with ASX · Mar 30, 2016 at 5:31 AM EDT

On 6ix: 6ix.com/news/starpharma-clinical-trial-programs-accelerating

View Attachment

6ix hasn’t read this filing yet.

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

  • Starpharma receives $4.2M R&D tax incentive refundMar 30, 2016
  • SPP Record Date ClarificationMar 30, 2016
  • SPL: VivaGel condom approved for sale with launch imminentMar 30, 2016
  • DEP docetaxel - longer duration and increased exposureMar 30, 2016
  • Adama Licenses Starpharmas Priostar for Novel 2,4-DMar 16, 2016

Later from Starpharma

  • ARC grant for Starpharmas targeted drug deliveryMar 30, 2016
  • Reduced neurotoxicity - SPLs dendrimer enhanced oxaliplatinMar 30, 2016
  • SPLs dendrimer a potential viral conjunctivitis treatmentMar 30, 2016
  • SPL Signs Priostar Agrochemical Partnership with GowanMar 30, 2016
  • Starpharma Dendrimer-Docetaxel eliminates neutropeniaMar 30, 2016
All Starpharma news releases↗

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer